{
  "created_at": "2020-01-13T12:07:52.000Z",
  "updated_at": "2021-01-06T08:24:48.644Z",
  "id": "b052c8f9-8a12-49ae-afc5-a25b8d359395",
  "labels": "current-affairs,2020-01-14",
  "question": "With reference to the recent news coverage of the drug ‘Quadrimune’, consider the following statements:<br />\r\n<ol>\r\n<li>It is for treatment of AIDS.</li>\r\n<li>It need not be refrigerated.</li>\r\n</ol>\r\nWhich of the above statements is/are true?",
  "option1": "Only 1 is correct",
  "option2": "Only 2 is correct",
  "option3": "Neither 1 nor 2 is correct",
  "option4": "Both 1 and 2 are correct",
  "option5": "",
  "answer": "Both 1 and 2 are correct",
  "explanation": "<strong>Statement 1 is correct:</strong>\r\nThe recently introduced Quadrimune is a drug for treatment of AIDS among children. It was developed by pharmaceutical giant Cipla as one of the pioneers of inexpensive anti- AIDS drug. While the currently available drugs are priced at 10,000 to 15,000 USD per year for a patient, the Quadrimune is to be priced at 350 USD per year for a child patient.\r\n <strong>Statement 2 is correct:</strong>\r\nThe Quadrimune is a combination of 4 drugs and is powdery in texture. This enables the healthcare workers to overcome the issue of palatability for children. The drug also doesn’t require refrigeration. It is to be sold in the form of pellets and to have strawberry flavour."
}